Zhen Wang
Fang Qi1,2
Guangchao Xu
Dali Wang- 1Department of Plastic Surgery and Burns, Affiliated Hospital of Zunyi Medical University, Zunyi, China
- 2The Collaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine of Zunyi Medical University, Zunyi, China
Wound healing is a dynamic and highly regulated process that can be separated into three overlapping and interdependent phases: inflammation, proliferation, and remodelling. This review focuses on the inflammation stage, as it is the key stage of wound healing and plays a vital role in the local immune response and determines the progression of wound healing. Inflammatory cells, the main effector cells of the inflammatory response, have been widely studied, but little attention has been paid to the immunomodulatory effects of wound healing in non-inflammatory cells and the extracellular matrix. In this review, we attempt to deepen our understanding of the wound-healing microenvironment in the inflammatory stage by focusing on the interactions between cells and the extracellular matrix, as well as their role in regulating the immune response during the inflammatory stage. We hope our findings will provide new ideas for promoting tissue regeneration through immune regulation.
Introduction
Wound healing involves the cooperation between several different cell types and the involvement of various growth factors, cytokines, and the extracellular matrix (ECM), which together contribute to three overlapping phases: inflammation, proliferation, and remodelling (1). Inflammation initiates the process of wound healing, which is critical to protect the body from pathogens and to remove necrotic tissue. However, excessive inflammation can lead to the persistence of chronic non-healing wounds, preventing the wound from proceeding to the remodelling stage, thereby delayed healing (2). To strictly control the balance between inflammatory activation and inhibition, and to prevent excessive or abnormal inflammatory reactions, it is necessary to comprehensively understand the inflammatory microenvironment of skin wounds.
Crosstalk activation between the platelet cascade reaction and the complement system initiates the wound repair process. As the first circulating cells are recruited to the inflammatory microenvironment, neutrophils play a role in the resistance to bacterial invasion (3). Subsequently, monocytes are recruited within 48-96 h after injury and transformed into tissue-activated macrophages (4). At the same time, the adaptive immune system, including mast cells, dendritic cells (DCs), and T lymphocytes, is activated against self and foreign antigens (1, 5). Inflammatory cells play an important role in the inflammatory stage during wound healing, but the function of non-inflammatory cells and the ECM cannot be ignored. Some subsets of non-inflammatory cells, such as keratinocytes, fibroblasts, and vascular endothelial cells, also play a role in regulating immunity (6). In addition to providing support and protection, the ECM is intimately associated with the adhesion and migration of immune cells (7). Therefore, inflammatory cells, non-inflammatory cells, and the ECM constitute the immune microenvironment of a wound, and their interactions are key to the regulation of wound healing (Figure 1).
Figure 1 Inflammatory microenvironment of skin wounds. Inflammatory cells: neutrophils, macrophages, mast cells, T cells, DCs, platelets and complement; non-inflammatory cells: fibroblasts, keratinocytes and vascular endothelial cells; extracellular matrix: fibrin, FN, HA and HS.
In this review, we provide an up-to-date and detailed overview of the contribution of inflammatory cells, non-inflammatory cells, and the ECM to the wound microenvironment. We will focus on the non-inflammatory cells and the ECM in our review, which are two topics that have not received as much attention from a clinical perspective. Finally, we discuss how cell-cell and cell-ECM interactions regulate immune response in the wound microenvironment.
Role of Inflammatory Cells in the Inflammatory Microenvironment
The inflammatory cascade is activated after haemostasis and coagulation. Neutrophils, macrophages, and lymphocytes respond to injury signals and are recruited from circulation to the wound microenvironment in a specific spatiotemporal order (8). Additionally, there are resident immune cells, including mast cells, DCs, and T lymphocytes (9). Together, they constitute the inflammatory cells of the wound inflammatory microenvironment and play an immunomodulatory role after skin injury.
Neutrophils
Neutrophils are the first circulating immune cells that are recruited to the wound microenvironment. They can remove bacteria and necrotic tissue by releasing protease-containing particles or by degrading microorganisms in phagocytic cups. In addition, the inflammatory cascade depends on the hydrogen peroxide gradient formed by the neutrophil-releasing enzyme complex nicotinamide adenine dinucleotide phosphate oxidase (NADPH) and reactive oxygen species (ROS) (10). ROS participate in redox signal transduction to promote cell migration, proliferation, and renewal. Activated neutrophils also form prominent extracellular structures called neutrophil extracellular traps (NETs) (11). These structures extend to the extracellular microenvironment by nuclear budding or chromatin release to capture and eliminate pathogens. However, their high cytotoxic potential also means that their activation and migration need to be strictly regulated to prevent excessive inflammation from damaging tissue. Neutrophils not only inhibit healing by releasing soluble mediators and excessive ROS but they also secrete particles with pro-inflammatory microRNAs (miR-23a and miR-155) that can cause tissue damage (12). Wong et al. showed the deletion of key NETosis enzymes, or the inhibition of the “Nod-like receptor protein(NLRP3) inflammasome-NETs” inflammatory loop, can improve angiogenesis and accelerate wound healing (13). The neutropenia model can accelerate the speed of wound epithelial closure without changing the overall quality of the wound healing process. Therefore, timely removal of neutrophils from the inflammatory microenvironment is of great significance for wound healing.
Neutrophils undergo apoptosis or necrosis after the removal of bacteria and necrotic tissue and are engulfed by macrophages through efferocytosis. A subset of neutrophils leave the injured site and return to the circulatory system by neutrophil reverse migration (14). However, neutrophils that are not cleared by these two processes develop secondary necrosis, resulting in the release of pro-inflammatory factors and cytotoxic molecules that result in tissue damage (Figure 2A). Clearing neutrophils from damaged areas is one of the principles of hyperbaric oxygen therapy that can enhance the healing ability of diabetic ulcer and chronic wound patients (15).
Figure 2 Role of the neutrophils and macrophages in wound inflammation. (A) Neutrophils produce extracellular trapping nets of neutrophils, trigger phagocytosis, produce oxidative bursts and degranulation to remove bacteria and necrotic tissue. It,s cleared by burial, reverse metastasis of neutrophils and secondary necrosis of neutrophils; (B) Macrophages removal cell fragments, pathogens and apoptotic cells, and produce a large number of pro-inflammatory cytokines to recruit immune cells. Polarization to M2 type under the influence of TH2 cytokines, apoptotic cells, nucleotides and temporary extracellular bases.
Macrophages
After neutrophils are established, circulating monocytes quickly enter the tissue in response to injury signals and transform into macrophages after exposure to the local inflammatory microenvironment (1, 8). At the same time, a small number of resident macrophages near skin capillaries quickly recognise injury signals by expressing purine-producing receptors and promote the recruitment of inflammatory cells to the injured site (16). Although macrophages are involved in all stages of repair, their phenotypes and functions are regulated by the surrounding environment (17). Based on their different roles in wound repair, macrophages can be roughly assigned to three types: inflammatory macrophages, decomposing macrophages, and tissue remodelling macrophages (17). M1 macrophages that express high levels of the cell surface markers lymphocyte antigen 6 complex(Ly6c) and CC-chemokine Receptor 2(CCR2) are the main activated phenotypes in the inflammatory microenvironment. They act as phagocytes, as they remove cell fragments and pathogens, and clean wounds (18). When they phagocytise many apoptotic neutrophils, they can induce the progression from an inflammatory to a proliferative microenvironment (4, 19). These macrophages also produce and secrete high-levels of pro-inflammatory factors such as tumour necrosis factor-α (TNF-α), interleukin 1β (IL-1β), and cyclooxygenase-2, as well as other inflammatory cells that are recruited to participate in pathogen clearance (20). Lucas et al. and Goren et al. administered diphtheria toxin to lysM-Cre/DTR mice and observed a rapid decrease in the number of macrophages in injured skin, which resulted in serious damage to the wound shape and delayed healing (21, 22). In a prospective randomized trial, treatment of deep second-degree burns with recombinant human granulocyte macrophage colony-stimulating factor increased tissue macrophage count, enhanced immune response to local wounds, and ultimately accelerated wound healing (23). Although M1 macrophages have strong antibacterial ability, their persistence at the wound site may lead to MMP9 secretion and tissue damage (20). Therefore, the timely polarization of M1 macrophages is very important to promote the process of wound healing. In diabetic mice, wound healing was promoted through enhancement of the polarization from M1 to M2 (24). T helper-2 (Th2) cytokines and apoptotic cells that are present in the inflammatory microenvironment can promote the polarisation of M1 macrophages. This is accomplished under the synergistic action of nucleotides and the temporary ECM (25, 26) (Figure 2B). The world’s first treatment of diabetic foot ulcers using macrophage regulation (R&D code: ON101) has successfully completed a phase III clinical trial, demonstrating that targeting macrophage phenotypes is an effective method for the clinical treatment of chronic wounds (27).
Mast Cells
Mast cells are immune cells that originate from the bone marrow and are located around blood vessels in the dermis, peripheral nerves, sebaceous glands and sweat glands (28, 29). They are the key effectors in mediating allergic reactions, and their role in host resistance to bacterial invasion has also been widely recognized. Tissue injury activates mast cells and releases prefabricated or de novo mediators into the inflammatory microenvironment, such as histamine, serotonin, and secretory granules (e.g., chymotrypsin, elastase, and trypsin) (28–30). Among them, histamine promotes skin wound healing by upregulating the expression of basic fibroblast growth factor (bFGF) to recruit macrophages and promote angiogenesis during the period of inflammation (31). The combination of trypsin and PAR2 on vascular endothelial cells causes telangiectasia and mediates neutrophil infiltration to the injured site (32). Inflammatory mediators, such as TNF-α, MMP-2, and IL-8, have also been shown to be effective in recruiting neutrophils and activating macrophages in the inflammatory phase (5). Studies on mast cell deficiency in mice have shown that it is closely related to impaired neutrophil recruitment (33). In some cases, however, too many mast cells can hinder wound healing. A study on mast cells in the skin of patients with type 2 diabetes showed that high expression of IL-3R mast cell clusters may be associated with chronic skin inflammation (34). McS-01, an indole-carboxyamide-type mast cell stabilizer developed by Tellechea et al., was shown to polarize macrophage phenotypes to accelerate wound healing in diabetic mice (35). However, many studies have shown that mast cells play a role in the proliferation stage of wound healing, especially in granulation tissue formation, fibroblast proliferation, and angiogenesis (36, 37). Scarless healing was transformed into scar formation by injecting mast cell lysates into mouse embryonic wounds (38). Notably, different microenvironmental stimuli can lead to differences in mast cell subtypes (39).
DCs
Different subsets of DCs in the skin are recruited after tissue injury, including epidermal Langerhans cells (LCs), dermal DCs, and plasmacytoid DCs (pDCs). LCs are anchored to adjacent keratinocytes by the adhesion molecule E-cadherin (40). LCs maintains their count through self-renewal, and inflammatory stimulation enhances LC migration and local proliferation (41, 42). The formation of long and intricate dendritic structures between keratinocytes facilitates their rapid response to tissue damage (43). After skin injury, LCs migrate to lymph nodes under the stimulation of pro-inflammatory cytokines, IL-1β and granulocyte macrophage colony stimulating factor, and present injury or pathogenic antigens in the wound microenvironment to CD4T cells to induce an immune response (42). A previous study has shown that the greater the number of LCs in diabetic foot ulcers, the better is the healing effect, suggesting that human LCs play a beneficial role in the inflammatory wound-healing microenvironment (44). Clinical zinc supplementation in patients with bedsore can induce a high proportion of LC expression in wound marginal epidermis and significantly accelerate the healing process (45). However, different results were obtained when langerin(+) cells and CD11c+ cells were depleted in Lang-DTR and CD11C-DTR mouse models, respectively. The former promoted healing while the latter induced the opposite (46). The different results may be due to the use of different mouse LC depletion models. Therefore, while targeting LCs holds great potential for clinical wound healing, gaps in its understanding of the skin wound healing process need to be addressed. There are several other subtypes of dermal DCs. CD141+ DCs, which stimulate CD8+ T cell immunity by secreting IL-12 and thereby promote Th-1 differentiation (47, 48). CD1C+ DCs present CD4+ T cell antigens (47). In addition, after a skin injury, pDCs enter the inflammatory microenvironment and express Toll-like receptor (TLR)-7 and TLR-9, which recognise viral nucleic acids and induce an early inflammatory response (47, 49). A lack of pDCs in the wound healing microenvironment impairs acute inflammatory responses and delays wound healing (49). With the development of single-cell sequencing, the origin of DCs and their development in skin will be further clarified.
T Lymphocytes
There are many different types of T lymphocytes in the epidermis and dermis. Dendritic epidermal T cells (DETCs) are the main type of T cells in the epidermis and form a cross-network with LCs by extending dendrites to the basal layer (50). DETCs are involved in the process of skin wound healing with the participation of mTOR, aromatic receptors, and STAT signaling pathway. DETCs become round after tissue injury and release CCL-3, CCL-4, CCL-5 and lymphocyte chemokines to regulate the migration of inflammatory cells (51, 52). In the presence of DETCs defects, wound closure in injured mice is delayed (52). Tissue injury around dermal hair follicles induces the accumulation of a large number of activated CD4+ helper T cells (Th) in the skin. Five major Th subgroups are known: Th1, Th2, Th17, Treg (T regulatory cells), and Tfh (follicular T helper cells). All Th subgroups show differences in cytokine release after skin injury, such as decreased IFNγ secretion by Th1 and increased IL-10 and IL-17 release by Th2 and Th17 (53). Th1 and Th2 can activate M1 and M2 macrophages, respectively, and Th17 can continuously recruit neutrophils; however, the direct impact of these cell types on wound healing is still unknown (54). Tregs are currently becoming the target of research into the relationship between Th and skin trauma. The aggregation of Tregs limits or eliminates damage in the early stages of trauma-related inflammation. When Tregs were depleted during the inflammation phase in the skin of injured mice, significantly higher levels of pro-inflammatory macrophages were observed and wound closure kinetics were significantly delayed (55). Independent of their immunomodulatory function, Tregs have also been found to have a regenerative effect that promotes cell differentiation (56). In addition, constant natural killer T cells promote wound healing by preventing the prolonged inflammation that is mediated by neutrophils and have been shown to accelerate wound healing in mice (43). Clearly, there are many permanent and circulating lymphocytes that are recruited to the wound healing microenvironment, but their different functions need to be further clarified.
Platelets
In addition to playing a role in haemostasis and thrombosis, platelets are also involved in the regulation of immune responses during inflammation. Adhesion molecules and pattern-recognition receptors are distributed on the surface of these non-nucleated cells, enabling platelets to receive signals from the microenvironment and interact with other cells or the ECM. Activated platelets adhere to fibrinogen in the ECM via integrins β1, β2, and β3 on the cell surface. TLR4 and CD40L mediate the formation of NETs and the production of ROS (57, 58). Platelets have protein synthesis function that enables them to have bioactive protein libraries stored in their granules and vesicles and to release these stored proteins when activated by signals. A variety of chemokines and growth factors contained in α-particles can recruit immune cells from circulation, such as platelet-derived growth factor, platelet factor 4, chemokine C-C-motif ligand(CCL)5, and chemokine C-X-C-motif ligand(CXCL)4, which contribute to the recruitment and degranulation of neutrophils as well as the regulation of the polarization of macrophages (59). P-selectin, an adhesion molecule secreted by α- particles, interacts with P-selectin glycoprotein ligand-1 deficient(PSGL-1) expressed on immune cells as a key mediator of platelet-mediated immune cell rolling (57). The release of 5-HT from dense granules promotes the recruitment of neutrophils (59). In addition to the recruitment of immune cells, proteins containing defensins and antimicrobial peptides(AMPs) are released by platelets to contribute to the defence mounted against invading microbes (60). In addition, platelets release microvesicles after activation. These platelet-derived microvesicles not only deliver signalling molecules including mRNA and miRNA to the microenvironment, but also serve as the main pathway for the secretion of IL-1β by platelets (61, 62). Simply put, activated platelets release many proteins that help heal wounds. Platelets effectively promote wound healing by inducing the polarisation of macrophages from the pro-inflammatory phenotype to the repair phenotype (63). Interestingly, by exploring the protein heterogeneity within platelet particles, researchers have found that the protein uptake and packaging by platelets may be influenced by disease status (63). This may be the reason why studies have found that dermal matrix with platelets during wound inflammation can significantly promote fibroblasts proliferation and migration but has no obvious anti-inflammatory effect (64). The clinical application of platelet-rich plasma (PRP) in the field of regenerative medicine has been widely recognized and discussed. According to cell composition and fibrin content, platelet concentrators are divided into four categories: pure platelet-rich plasma (P-PRP), leukocyte-rich and platelet-rich plasma (L-PRP), pure platelet-rich fibrin (P-PRF) and leukocyte-and platelet-rich fibrin (L-PRF) (65). The results of a randomized controlled trial showed that L-PRP treatment after total hip arthroplasty could quickly close skin incisions (66). Huang et al. proposed a new type of platelet lyophilization therapy, which can improve wound healing rate and overcome the drawbacks of non-standardized and long-term PRP storage (67). To summarise, although researchers have realised that platelets are not only related to haemostasis, but also closely related to immune response, further studies are needed to confirm whether this association affects the local immune response or even wound healing efficiency during skin wound inflammation (Figure 3).
Figure 3 Role of the platelets in wound inflammation. Platelets mediate the migration of immune cells through contact with ECM and other cells through surface adhesion molecules and pattern recognition receptors, and release α-particles, dense granules, microvesicles and antimicrobial peptides.
Complement
The complement system is an intricate network of immune responses made up of a series of proteins that are activated after trauma to participate in the removal of microorganisms and damaged cells. In addition to the large amount of complement proteins provided by the liver, complement proteins are also produced in immune cells, fibroblasts and keratinocytes (68, 69). Complement proteins form C3 convertase through an alternative pathway, a lectin pathway or a classical pathway. C3 is then cut into small fragment C3a and large fragment C3b. C3b attaches to the pathogen surface in combination with C3 convertase to form C5 convertase, which then cuts C5 into small fragment C5a and large fragment C5b. Subsequently, C5b forms a membrane-attacking complex with C6, C7, C8, and C9, which produces holes in the surface of the pathogen, resulting in pathogen cleavage (70). Small fragments C3a and C5a act as effective inflammatory mediators to recruit inflammatory cells to the injured site (71). C3a also affects vasodilation and infiltration, resulting in local histamine release, vascular permeability and increased inflammatory cell infiltration; C5a has been shown to promote the migration and oxidative explosive power of macrophages and neutrophils during wound inflammation (72, 73). The application of C3 and C5 in collagen carrier alone or in combination was able to promote collagen deposition 3 days after trauma, thus increasing the maximum wound strength in a rat incision model, indicating the beneficial effect of complement (74–76). However, the increase of complement degradation factor C3d in burn wounds and C3 in the serum of patients with chronic leg ulcers suggested the negative effect of complement on wounds (77). In the study of a skin-wound model of C3 or C5 deficient mice, it was found that blocking the complement activation pathway could reduce the intensity of inflammation and accelerate the rate of early healing (78, 79). Similar results of rapid wound healing were observed in Cynomolgus monkeys treated with C3 inhibitor Cp40 (80). Excessive activated complement that affects wound healing in diabetic wounds can also be controlled by complement C1 peptide inhibitors to restore the level of wound healing (81). In addition, complement protein C1q was found to be involved in angiogenesis in wound healing independent of the complement activation pathway (69). Low-molecular-weight heparin tinzaparin sodium is used in the treatment of thrombosis-related diseases with its anticoagulating properties, but its potential to inhibit complement fixation and C5a liberation may improve skin inflammation (82). The above results suggest that the inhibition of complement activation is an effective way to stimulate wound healing. In clinical practice, although complement inhibitors have been used to treat patients with acute and chronic inflammation, no clinical studies have been done to test their actual efficacy in chronic wound of the skin (77).
Role of Non-Inflammatory Cells in the Inflammatory Microenvironment
Non-inflammatory cells (keratinocytes, endothelial cells, and fibroblasts) in the wound microenvironment are mainly involved in neovascularisation, granulation tissue, and re-epithelialisation during proliferation and reconstruction (1). Thus far, their roles in these processes have been extensively reviewed. Interestingly, these cells are not idle in the inflammatory microenvironment, but there are few functional descriptions of their role in this phase. Keratinocytes and fibroblasts can secrete cytokines, chemokines, and bioactive material to participate in pathogen clearance and immune regulation. Furthermore, vascular endothelial cells use a well-known emigration mechanism to transport circulating immune cells to tissue.
Keratinocytes and Fibroblasts
TLRs are transmembrane proteins that consist of leucine-rich repeats. Thirteen members of the TLR family have been identified and 10 of these are expressed in humans (6). As pattern recognition receptors, TLRs recognise pathogen-associated molecular patterns in response to microorganisms and damage-associated molecular patterns in response to tissue and cell damage. TLRs trigger pro-inflammatory responses, promote immune cell recruitment and antigen presentation and thus participate in local immune responses (83). They are expressed in most inflammatory cells of the skin, such as macrophages and DCs, and have been demonstrated in keratinocytes, fibroblasts, and other non-inflammatory cells (84). Epidermal keratinocytes have been shown to express TLR-1 through 6, TLR-9, and TLR-10, and fibroblasts express TLR-1 through 10 (6).
In intact skin, keratinocytes are closely connected to adjacent epithelial cells through desmosomes and to the extra cellular matrix of the underlying basement membrane through semi-desmosomes (85). After early skin injury, the TLRs of keratinocytes sense damage signals and secrete antimicrobial factors such as AMPs to clear pathogens (9, 86). In addition, keratinocytes activate the NF-kB pathway to release pre-stored cytokines such as IL-1α and TNF-α, during injury, initiating and amplifying the pro-inflammatory signal cascade (87, 88). Subsequently, keratinocyte-derived CCL27 and CCL20 allow recruitment of LC and T cells from circulation to the inflammatory site, while rapidly activating resident immune cells (88).
Fibroblasts, as dermal interstitial cells, repair wounds, mainly through cell proliferation and collagen deposition after tissue injury. The transcriptional analysis of fibroblasts has shown that many immune gene loci have transcriptional potential (89). Under the activation of IL-α released by keratinocytes and TLR ligands in the wound microenvironment, fibroblasts activate the NF-kB pathway for the induction and recruitment of inflammatory cells by proinflammatory cytokines (TNF α, INF γ, IL-6, IL-8), chemokines (CCL1, CCL2, CCL5, CXCL1, CXCL8, and CXCL10), and growth factors (granulocyte/macrophage colony stimulating factor (GM-CSF) and granulocyte colony stimulating factor (G-CSF) (4, 9, 90, 91). CCL2 is closely associated with monocyte recruitment (92). Like keratinocytes, fibroblasts also synthesise AMPs and defensins (hBD-1 and hBD-2) to clean wounds (9, 93). In addition, vascular endothelial growth factor-A, which is synthesised by fibroblasts, is involved in angiogenesis in the inflammatory microenvironment and can recruit monocytes/macrophages (94) (Figures 4A, B).
Figure 4 The role of keratinocytes, fibroblasts and vascular endothelium in wound inflammation. (A) Toll-like receptors activate cells to secrete cytokines, chemokines recruit immune cells, and synthesize antimicrobial peptides to kill pathogens; (B) Toll-like receptors activate cells to secrete cytokines, chemokines and colony-stimulating factors to recruit immune cells, while synthesizing antimicrobial peptides and defensins to kill pathogens, but also participate in new angiogenesis, conducive to immune cells clear and moist; (C) Circulating immune cells infiltrate into the injured tissue through capture, slow rolling, regulation of adhesion strength, crawling in the lumen, and eventually cross-cell or paracellular migration.
Although the immunomodulatory effects of the two abovementioned types of cells in the inflammatory period of wound healing can be affirmed, at present, skin grafts are mostly used to seal the wound by using their proliferation and differentiation abilities. Apligraf® has been approved as an allograft in several countries for the treatment of acute wounds (95). Randomized controlled trials conducted by Poinas et al. have shown that biological dressings composed of foetal fibroblasts and keratinocytes show low immunogenicity and high regeneration efficiency, and they are expected to substitute skin allografts (96).
Vascular Endothelial Cells
Vascular endothelial cells are a barrier and sensor between the circulation and basic tissue and are the key effectors that regulate the entry of circulating immune cells into the inflammatory microenvironment. Under the stimulation of wound injury signals, circulating immune cells can pass through vascular endothelial cells through the process of capture, slow-rolling, adhesion intensity regulation, intraluminal crawling, and finally cross-cell or paracellular migration, which is a dynamic balancing process (97, 98). Stimulated by pro-inflammatory factors, endothelial cells express L-selectin, E-selectin, and P-selectin, which bind to ligands (LFA-1 and Mac-1) on circulating immune cells (47). These mediate circulating immune cell capture from fast-flowing blood and slow them down as they adhere to endothelial cells. Subsequently, heterodimer adhesion molecules called integrins, such as intercellular cell adhesion molecule(ICAM)-1 and ICAM-2, mediate the strong adhesion of circulating immune cells to the vascular endothelium (98). Finally, circulating immune cells crawling on the surface of vascular endothelial cells infiltrate the wound microenvironment through the paracellular pathway under the influence of chemokines (99). Under normal conditions, the intact polysaccharide-protein complex/endothelial surface layer can be used to inhibit the adhesion of circulating immune cells to vascular endothelial surfaces (100). In addition, vascular endothelial cells produce many cytokines and chemokines, such as TNF-α, IL-1, and IL-6 (101). Although vascular endothelial cells expressing TLR-2, and TLR-4 can mediate inflammation through NF-κB and MAP kinases, the role of TLRs expressed by these cells in wound healing needs to be further elucidated (102) (Figure 4C). Among a large number of skin substitutes, vascular endothelial cells partially derived from adipose matrix can achieve vascular network regeneration in diabetic wounds, but there is still no study on the mechanism of their immunomodulatory effect (103).
Role of the ECM in the Inflammatory Microenvironment
The ECM is a complex and dynamic structure that not only acts as a scaffold for cells and tissues but also interacts with cells to produce regulatory signals for cell migration, proliferation, differentiation, and apoptosis (104). ECM components play an important role in every stage of wound healing and are constantly remodelled during the repair process; however, this section focuses on the function of the ECM in the inflammatory microenvironment. In the case of tissue injury, the temporary matrix formed on the wound provides a scaffold for the infiltration of immune cells. Additionally, the ECM at the edge of the wound can transmit damage signals to immune cells and guide their infiltration. ECM scaffolds provide mechanical support for cell regeneration and tissue repair, creating a natural microenvironmental niche (105).
Temporary ECM
In 1998, Magnusson et al. described the temporary ECM of wound healing as “early” stage and “late” stage (106). The early, temporary matrix is formed immediately after vascular injury and consists of platelets, plasma proteins [such as fibrin, fibrinogen, fibronectin (FN), hyaluronic acid (HA), heparin sulfate(HS)], which infiltrate the wound site, prevent blood loss, and provide a temporary scaffold for subsequent infiltration of immune and repair cells (106–109). Subsequently, neutrophils, macrophages, and lymphocytes successively enter the inflammatory microenvironment and establish the late temporary matrix (105, 106). Fibrin, which is derived from profibrinogen, is the main component of the early temporary matrix and is upregulated in response to injury and inflammation (110). In addition to providing the necessary cellular support for immune cells, fibrin can also bind to integrin receptors on the surface of immune cells to mediate cell migration, such as neutrophils and inflammatory macrophages that bind to fibrin through their αMβ2 integrin receptors (111). As repair progresses, more plasma FN is deposited and becomes the main component of the late temporary matrix (106, 110). A study of rat skin wounds showed that the level of FN mRNA increased significantly after injury (111). FN can stimulate cell migration and adhesion by connecting actin filaments through integrins (112). It can also activate macrophages to secrete TNF-α, IL-6, and IL-8 (87). Besides, proteoglycan HA and HS are also present in the temporary matrix. HA increases in early repair stages and can both activate inflammation as a proinflammatory factor and limit inflammatory damage. The former mainly mediates cell migration and increases inflammatory cell infiltration by binding to immune cell surface receptors (CD44, ICAM-1 and RHAMM), while the latter eliminates tissue damage caused by inflammation by scavenging free radicals and matrix degrading enzymes (113). The HA content in the foetal wound microenvironment is higher and lasts longer compared to adult wounds, and exogenous HA has a beneficial effect on wound healing (114). HS is a temporary substrate, produces growth factors needed during wound healing,such as fibroblast growth factor, platelet-derived growth factor and transforming growth factor-β (115). And it may play an important role in promoting the migration of neutrophils to the wound site (115).
After infiltrating the wound microenvironment through the vascular endothelium, circulating immune cells need to travel through the ECM to reach the edge of the wound and then infiltrate the temporary matrix. In this process, the ECM structure acts as a scaffold for immune cell adhesion and tissue structure, and produces cytokines, growth factors, and molecules and their derivatives, which promote the activation and migration of immune cells (116). Because epidermal cells are closely bound to the basement membrane, the ECM of the dermis is further explored here. Mechanical damage and pathogen invasion can cause the decomposition of macromolecular components such as fibrin, adhesive glycoproteins, and glycosaminoglycan in the ECM and release related molecules with pro-inflammatory functions (117). Matrikines are fragments produced by partial proteolysis, and these molecules and their derivatives in the ECM can coordinate the entry of immune cells into the inflammatory microenvironment by remodelling the tissue cytoskeleton and regulating signal transduction (118). At the same time, chemotactic gradients are formed on the wound surface to limit the access of specific cell subsets to the local inflammatory microenvironment (116) (Figure 5).
Figure 5 The role of ECM in the inflammatory microenvironment. (A) The early temporary matrix: mainly fibrin, playing the role of hemostasis and providing scaffold; (B) The late temporary matrix mainly plasma fibronectin, inducing cell activation and migration; (C) Dermal ECM: providing support and promoting cell migration.
Based on the importance of the ECM in wound healing, biomaterials simulating ECM have been widely used in the clinic. ECM substitutes provide temporary support and migration sites for cells to close the wound. Harding et al. reported that a synthetic biomimetic acellular matrix was used as a substitute for ECM in the treatment of refractory leg ulcers, which proved its effectiveness and safety (119). In addition, ECM used to treat diabetic foot ulcers can produce clinical results similar to those of human fibroblast-derived dermal substitutes, but at a lower cost (120). It is worth noting that current research on a variety of biosynthetic materials is inseparable from the composition of the ECM, especially the application of fibrin and collagen.
Mechanical Signalling of the ECM
Although the regulation of the behaviour and fate of immune cells by growth factors and signalling molecules in the ECM has been extensively studied, mechanical signalling is equally important in activating immune cells during tissue regeneration. The influence of the mechanical signals of the ECM on cell behaviour is mainly mediated by integrin receptors. Integrin is a bidirectional transmembrane receptor composed of α and β subunits (121). When mechanical signals from the ECM generated by tissue injury induce conformational changes in the extracellular domain of integrins, activated integrins activate intracellular signalling pathways to regulate gene expression (122, 123). Activated integrins recruit a large number of mechanically sensitive proteins (such as Talin and Vinculin) to assemble into nascent adhesions (NAs) and deliver a reverse thrust to the ECM via actin. Subsequently, NAs degrade rapidly, and adherent plaque kinase recruits ARp2/3 (actin cytoskeletal nucleating agent) to form adherent plaque (FAs) to drive cell migration (124). αDβ2 and αMβ2 are expressed on the cell surface of macrophages and can migrate to inflammatory sites in response to the mechanical stress of the ECM (125, 126). In addition, activation of mechanically gated ion channels has been shown to play a role in mechanical transduction of immune cells, for example, Piezo1 and instantaneous receptor potential cation channels (TRP). Piezo1 channels on macrophages, activated by mechanical stimuli, mediate the influx of Ca2+, resulting in the production of pro-inflammatory mediators such as IL-6, TNF-α and prostacyclin E2 (123). Research shows that Piezo1-deficient macrophages reduce inflammatory cell infiltration during wound healing (127). TRPV4 is the most studied mechanically gated TRP channel and is widely expressed in immune cells. Activated TRPV4 binds to F-actin to mediate the extravasation of neutrophils and macrophages into injured and inflammatory sites (128). In response to mechanical signals from the ECM, cytoskeletal F-actin mediates the entry of cardiac-associated transcription factors (MRTF) and YAP/TAZ transcription factor complexes into the nucleus to regulate gene expression. Nuclear expression of YAP and the NF-κB pathway crosstalk up-regulate the expression of pro-inflammatory cytokines in macrophages (129). Therefore, the proliferation and migration of immune cells require the generation and transmission of mechanical forces. The resting stress on human skin triples during wound healing (130). However, recent studies have found that the rigidity of the ECM environment is more likely to lead to excessive inflammation and scar hyperplasia (127). This idea was supported by skin damage studies in Prickly African mice (Acomys), where in high levels of repair were associated with low levels of inflammation associated with resting hypotonia (130). However, some researchers have proposed that the existing models for simulating ECM structural remodeling do not take into account the mechanical plasticity caused by the change of viscoelasticity of ECM with time. They proposed a discrete model to study the effects of ECM viscoelasticity on matrix remodeling and stress distribution (131). Therefore, in order to simulate the role of physiological ECM in wound healing, the mechanical interaction between cells and ECM should be considered in the synthesis of ECM biomaterials.
Physicochemical Factors of the ECM
Although the efficacy of physical therapy has widely recognised in the clinical treatment of wounds, the regulatory mechanism of this type of therapy has not yet been clearly elucidated. In addition to mechanical forces, other physicochemical factors of the ECM (humidity, temperature, oxygen, and pH) also regulate immune responses. Winter et al. proposed the concept of treating wounds with a moist microenvironment in 1962 (132). This is essentially the same as the traditional surgical therapy of “oasting pus to promote regeneration” in traditional Chinese medicine, which emphasises that wound healing requires a wet microenvironment. Maintaining a wet microenvironment for the wound is beneficial to the migration of inflammatory cells (133, 134). The moist environment created by saliva has been associated with rapid oral wound healing (135). Therefore, after determining and adequately treating the cause of the wound, maintaining moisture in the wound area can better promote healing. The use of a combination of collagen and foam helps to maintain the moist environment of the wound in patients with venous ulcers of the lower extremities, increase the perfusion of blood and oxygen into the wound, and thus promote angiogenesis (136). The temperature of normally healed wounds peaked 3 days after injury and then gradually decreased (137, 138). The wound temperature increases due to local dilation of blood vessels, allowing the body to deliver more oxygen and nutrients to the injured area (139). Low temperature may weaken the oxidative killing ability of neutrophils and the motility of macrophages, which may easily lead to wound infection (140, 141). Infrared light irradiation is a traditional wound care method, its principle is that it can promote blood circulation to accelerate wound healing through heating. Placing diabetic ulcer patients in a heated warm room can significantly improve the wound healing rate (142). Adequate oxygen is required for phagocytes to produce antibacterial reactive oxygen, so adequate oxygen is crucial for immune cells to phagocytose invading microorganisms (139, 143). The purpose of oxygen therapy is to provide an oxygen-rich microenvironment for wound healing, such as hyperbaric oxygen therapy, which is widely used in clinic. However, due to its limitations, researchers are developing a variety of oxygen-producing biomaterials as a source of oxygen release (144). Acidic pH enhances acute inflammatory responses by stimulating the migration and aggregation of neutrophils and macrophages, delaying spontaneous apoptosis, and prolonging the functional life of neutrophils (145, 146). In contrast, alkaline pH has been shown to adversely affect wound healing by reducing oxygen in the wound and providing an environment conducive to bacterial growth as well as by significantly inhibiting neutrophil motility (138, 147). Honey has been very popular in wound treatment since ancient times. The low PH value of honey can increase the oxygenation of the injured site, remove free radicals and promote healing (148).
Cell-Cell and Cell-ECM Interactions
After tissue injury, the platelet cascade reaction activates hemostasis and the complement system, which eventually leads to wound healing in the inflammatory phase. When circulating immune cells migrate to the inflammatory microenvironment, they must first adhere to vascular endothelial cells and bind to selectins, integrins, or adhesion molecules (30, 99). This binding is an important condition for the release of TNF-α-mediated neutrophils, which increase vascular permeability (98). They also secrete factors such as thrombin, which promote mast cell migration, proliferation, and local differentiation (30). Neutrophils in the early inflammatory microenvironment recognise damage signals and generate H2O2 gradients through respiratory bursts that initiate an inflammatory cascade. This process occurs in combination with cytokines and chemokines (e.g. CXCR1, CXCR2, and CCR1) that are released by activated macrophages, epidermal γδ+T cells, endothelial cells, fibroblasts, and keratinocytes (10, 14, 16, 50, 51). Rapid and transient accumulation of PDCs recruited by damaged keratinocytes occurs in parallel with increased neutrophil infiltration (49). Subsequently, mast cells are recruited and release trypsin-like enzymes, which bind to the protease-activated receptor 2 on endothelial cells, causing vasodilation and further amplification of the inflammatory response (5). This series of reactions promotes the accumulation of M1 macrophages in the injured site and plays a role in the phagocytosis of apoptotic cells and pathogens. Meanwhile, LCs anchored to adjacent keratinocytes by the adhesion molecule E-cadherin migrate from the epidermis to the dermis in response to CXCL12 from dermal fibroblasts and MCP-1 from keratinocytes (40, 44, 149, 150). They provide antigens to the immune response of memory T cells, which are recruited by CCL27 and produced by activated keratinocytes in the skin (151). However, a dynamic balance in the inflammatory response is necessary for active wound healing (55). Tregs can restrict the aggregation of pro-inflammatory macrophages, and M1 macrophages engulf apoptotic immune cells, indicating a transition from the inflammatory to the proliferative microenvironment of the wound surface (Figure 6).
Figure 6 Dynamic network of cell-cell interactions in an inflammatory microenvironment.
The ECM constitutes a place for tissue repair following trauma, and its macromolecules and their derivatives can regulate the activation and migration of inflammatory cells as well as the proliferation and differentiation of repair cells. The ECM component HS participates in immune cell migration and regulates the secretion of cytokines, chemokines, and growth factors (152). HA is involved in the regulation of macrophage phenotype (153). Fibrin and FN mediate monocyte migration and secretion of TNF-α, IL-1β, and IL-6 and stimulate the migration and adhesion of fibroblasts, keratinocytes, and endothelial cells through integrin receptors (104, 116). Various factors and enzymes released by activated cells can constantly supplement and reshape the components of the ECM (116, 154). Matrix metalloproteinases and other enzymes released by activated inflammatory cells can expose the migration sites of the ECM by cleavage of the basement membrane (105). The release of toxic particles by neutrophils causes the rapid degradation of fibrin by plasmin and elastase, and the degradation products can induce or amplify the inflammatory process (154). The factors and proteins expressed by repair cells can fill the defects in the ECM and supplement the cell factor library of the ECM. The ECM and its derivatives help to regulate the biological function of cells in the microenvironment, while factors, enzymes, and proteins secreted by cells modify the components of the ECM to form a dynamically balanced inflammatory microenvironment for wound healing. There are many kinds of ECM biomimetic materials for simulating wound repair that are rapidly being developed. The incorporation of fibrinogen and collagen I into biomimetic coaxial nano-scaffolds to solve wound inflammation significantly promoted wound repair (155). Taking advantage of the ECM scaffold potential, the ECM modified with silver nanoparticles (nAg) has both antibacterial and tissue regeneration abilities (156). However, the ECM is constantly being supplemented and reshaped, and the dynamic adjustment of the composition of the ECM to simulate the microenvironment needs further research and exploration.
Active wound healing depends on an orderly and moderate immune response regulated by inflammatory cells, non-inflammatory cells, and the ECM. Disruption of any of these links can lead to persistent inflammation and prevent the repair process, leading to the occurrence of chronic wounds such as chronic venous ulcers, diabetic foot ulcers, and pressure sores. These chronic wounds occur in the context of venous hypertension, diabetes, or angiopathy caused by prolonged tissue pressure (157). The destruction of vascular endothelial cells reduces the amount of blood perfusion to the wound area and causes tissue hypoxia (158). At the same time, the number of platelet-derived microvesicles in peripheral blood increases, and these microvesicles are internalised by vascular endothelial cells, thus up-regulating the expression of intercellular adhesion molecule-1 and resulting in more immune cells extravasating to the injured site (159). Neutrophil recruitment promotes the production of more NETs and activates the release of NLRP3 inflammatory bodies and IL-1β of macrophages through the TLR-4/TLR-9/NF-κB signal pathway (160). Although a large number of pro-inflammatory M1 macrophages are activated, phagocytosis of apoptotic neutrophils by these macrophages is inhibited, resulting in a disturbance in the process of macrophage polarization (161–163). With increase in the number of degranulated mast cells, a sustained inflammatory response is eventually achieved (164). The inflammatory cascade continues to cause the activation and accumulation of T cells, especially that of Th17 cells. Th17 cells secrete IL-17 to maintain the activity of M1 macrophages, leading to persistent inflammatory wound healing (162). On the contrary, increasing the number of LCs in the wound of diabetic mice has been shown to improve healing (165). A large number of pro-inflammatory factors increased the release of MMPs and accelerated the degradation of the ECM, which further reduced the proliferation and collagen deposition of fibroblasts (4, 166). In this pathological inflammatory microenvironment, inflammatory genes expressed by fibroblasts are up-regulated and keratinocytes release IL-1α and type I interferon, triggering an inflammatory chain reaction in adjacent stromal cells (92, 162). This, in turn, promotes the flow of immune cells into the injured site. In summary, the delay of chronic wound healing can be attributed to the failure of ECM remodelling caused by the uncontrolled immune regulation of inflammatory and non-inflammatory cells.
Discussion
We briefly reviewed the effects of the interaction of inflammatory cells, non-inflammatory cells, and the ECM on the inflammatory microenvironment of skin wounds. The spatial coexistence of functionally specialised cell types is a basic feature of multicellular organisms, and the different anatomical locations and degrees of interaction with other cells determine the functional differences in similar cells during the process of wound healing (i.e. cellular heterogeneity). For example, before circulating macrophages arrive, some tissue resident macrophages are already involved in the inflammatory response (16). Although different fibroblast subsets in human skin have been revealed, the unique gene expression changes in this population in skin wounds, especially in the inflammatory microenvironment, remain unknown (167). In addition, a wide range of cell types in wounds have significant plasticity under the influence of the ECM, which complicates the dynamic study of different cell subsets and their effects on wound healing. Single cell technology and space transcriptome technology, which are widely used because of the development of genomics technology, can solve the above problems step by step. The development and application of multiple sequencing technology can realise the unsupervised analysis of interactions among different cell types in skin wounds on the basis of restoring the spatial characteristics of tissue structure in vivo (168).
Correct and coordinated actions in the inflammatory microenvironment ensure proper wound healing. However, when this process is disrupted, skin healing is delayed, which eventually leads to chronic wounds. Compared with acute wounds, marrow-like cells (neutrophils and macrophages) in chronic wounds exist in large numbers for a long time, accompanied by the degranulation of mast cells and high expression of inflammatory T cell subtypes (169). The signal molecules and proteases secreted by these immune cells can also lead to the over-expression of pro-inflammatory cytokines and chemokines and continuous degradation of the ECM in non-inflammatory cells such as keratinocytes (170). Although many research groups have successfully promoted healing by regulating inflammatory cells, it is possible to induce an inappropriate immune response by directly regulating the immune system. Therefore, designing functional regulation based on non-inflammatory cells and the ECM provide a potential therapeutic approach for chronic wound healing.
Understanding the inflammatory microenvironment of skin wounds will help to develop a comprehensive understanding of the processes affecting wound healing. This information can provide personalised guidance for the strict control of wound immune response. In particular, research on the immune function of non-inflammatory cells and the ECM in wounds may reveal new strategies for the clinical development of innovative wound treatments.
Outstanding Questions
Several studies have shown that the inflammatory microenvironment is composed of inflammatory cells, non-inflammatory cells, and the ECM, which collaborate to scavenge necrotic cell fragments and prevent infection. The activation of repair-related cells promotes wound healing through the secretion of cytokines that lead to the proliferation stage. However, there is a need for further evidence to support the interactions between non-inflammatory cells and the ECM, which are involved in the immune regulation of the inflammatory microenvironment. Additionally, the functional advantages of all the inflammatory factors that control the inflammatory response needs to be elucidated. As the evidence that the reduction of inflammation can promote wound healing comes from the study of inflammatory cells, it is not clear whether the regulation of non-inflammatory cells and ECM can achieve the same or perhaps even a better immunomodulatory effect.
Author Contributions
Literature search and manuscript drafting, ZW and GX. Figures, ZW and HL. Manuscript editing and revision, GX, FQ, and DW. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by the National Natural Science Foundation of China [grant numbers 81871570 and 82072195], the Science and Technology Plan Project of Guizhou Province [grant numbers (2020)4Y148], the PhD Fund of Scientific Research Foundation of Affiliated Hospital of Zunyi Medical University[grant numbers (2020-03)], and the Chinese Ministry of Education [grant numbers 2020-39].
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgments
We thank Editage for providing language editing services.
References
1. Rodrigues M, Kosaric N, Bonham CA, Gurtner G. Wound Healing: A Cellular Perspective. Physiol Rev (2019) 99(1):665–706. doi: 10.1152/physrev.00067.2017
2. Pierce GF. Inflammation in Nonhealing Diabetic Wounds: The Space-Time Continuum Does Matter. Am J Pathol (2001) 159(2):399–403. doi: 10.1016/S0002-9440(10)61709-9
3. Palomino-Segura M, Hidalgo A. Immunity: Neutrophil Quorum at the Wound. Curr Biol (2020) 30(14):R828–30. doi: 10.1016/j.cub.2020.05.045
4. Boniakowski AE, Kimball AS, Jacobs BN, Kunkel SL, Gallagher KA. Macrophage-Mediated Inflammation in Normal and Diabetic Wound Healing. J Immunol (2017) 199(1):17–24. doi: 10.4049/jimmunol.1700223
5. Komi DEA, Khomtchouk K, Santa Maria PL. A Review of the Contribution of Mast Cells in Wound Healing: Involved Molecular and Cellular Mechanisms. Clin Rev Allergy Immunol (2020) 58(3):298–312. doi: 10.1007/s12016-019-08729-w
6. Portou MJ, Baker D, Abraham D, Tsui J. The Innate Immune System, Toll-Like Receptors and Dermal Wound Healing: A Review. Vascul Pharmacol (2015) 71:31–6. doi: 10.1016/j.vph.2015.02.007
7. Riley HJ, Bradshaw AD. Bradshaw, The Influence of the Extracellular Matrix in Inflammation: Findings From the SPARC-Null Mouse. Anat Rec (2020) 303(6):1624–9. doi: 10.1002/ar.24133
8. Su L, Zheng J, Wang Y, Zhang W, Hu D. Emerging Progress on the Mechanism and Technology in Wound Repair. BioMed Pharmacother (2019) 117:109191. doi: 10.1016/j.biopha.2019.109191
9. Tsepkolenko A, Tsepkolenko V, Dash S, Mishra A, Bader A, Melerzanov A, et al. The Regenerative Potential of Skin and the Immune System. Clin Cosmet Investig Dermatol (2019) 12:519–32. doi: 10.2147/CCID.S196364
10. Rosales C. Neutrophils at the Crossroads of Innate and Adaptive Immunity. J Leukoc Biol (2020) 108(1):377–96. doi: 10.1002/JLB.4MIR0220-574RR
11. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil Extracellular Traps Kill Bacteria. Science (2004) 303(5663):1532–5. doi: 10.1126/science.1092385
12. Butin-Israeli V, Bui TM, Wiesolek HL, Mascarenhas L, Lee JJ, Mehl LC, et al. Neutrophil-Induced Genomic Instability Impedes Resolution of Inflammation and Wound Healing. J Clin Invest (2019) 129(2):712–26. doi: 10.1172/JCI122085
13. Heuer A, Stiel C, Elrod J, Königs I, Vincent D, Schlegel P, et al. Therapeutic Targeting of Neutrophil Extracellular Traps Improves Primary and Secondary Intention Wound Healing in Mice. Front Immunol (2021) 12:614347. doi: 10.3389/fimmu.2021.614347
14. de Oliveira S, Rosowski EE, Huttenlocher A. Neutrophil Migration in Infection and Wound Repair: Going Forward in Reverse. Nat Rev Immunol (2016) 16(6):378–91. doi: 10.1038/nri.2016.49
15. Baiula M, Greco R, Ferrazzano L, Caligiana A, Hoxha K, Bandini D, et al. Integrin-Mediated Adhesive Properties of Neutrophils Are Reduced by Hyperbaric Oxygen Therapy in Patients With Chronic Non-Healing Wound. PloS One (2020) 15(8):e0237746. doi: 10.1371/journal.pone.0237746
16. Minutti CM, Knipper JA, Allen JE, Zaiss DM. Tissue-Specific Contribution of Macrophages to Wound Healing. Semin Cell Dev Bio (2017) 61:3–11. doi: 10.1016/j.semcdb.2016.08.006
17. Kim SY, Nair MG. Macrophages in Wound Healing: Activation and Plasticity. Immunol Cell Biol (2019) 97(3):258–67. doi: 10.1111/imcb.12236
18. Ganesh GV, Ramkumar KM. Macrophage Mediation in Normal and Diabetic Wound Healing Responses. Inflammation Res (2020) 69(4):347–63. doi: 10.1007/s00011-020-01328-y
19. Brown BN, Sicari BM, Badylak SF. Rethinking Regenerative Medicine: A Macrophage-Centered Approach. Front Immunol (2014) 5:510. doi: 10.3389/fimmu.2014.00510
20. Smigiel KS, Parks WC. Macrophages, Wound Healing, and Fibrosis: Recent Insights. Curr Rheumatol Rep (2018) 20(4):17. doi: 10.1007/s11926-018-0725-5
21. Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Müller W. Differential Roles of Macrophages in Diverse Phases of Skin Repair. J Immunol (2010) 184(7):3964–77. doi: 10.4049/jimmunol.0903356
22. Goren I, Allmann N, Yogev N, Schürmann C, Linke A, Holdener M. A Transgenic Mouse Model of Inducible Macrophage Depletion: Effects of Diphtheria Toxin-Driven Lysozyme M-Specific Cell Lineage Ablation on Wound Inflammatory, Angiogenic, and Contractive Processes. Am J Pathol (2009) 175(1):132–47. doi: 10.2353/ajpath.2009.081002
23. Yan D, Liu S, Zhao X, Bian H, Yao X, Xing J, et al. Recombinant Human Granulocyte Macrophage Colony Stimulating Factor in Deep Second-Degree Burn Wound Healing. Med (Baltimore) (2017) 96(22):e6881. doi: 10.1097/MD.0000000000006881
24. Fu J, Huang J, Lin M, Xie T, You T. Quercetin Promotes Diabetic Wound Healing via Switching Macrophages From M1 to M2 Polarization. J Surg Res (2020) 246:213–23. doi: 10.1016/j.jss.2019.09.011
25. Csóka B, Selmeczy Z, Koscsó B, Königs I, Vincent D, Schlegel P, et al. Adenosine Promotes Alternative Macrophage Activation via A2A and A2B Receptors. FASEB J (2012) 26(1):376–86. doi: 10.1096/fj.11-190934
26. McWhorter FY, Wang T, Nguyen P, Chung T, Liu WF. Modulation of Macrophage Phenotype by Cell Shape. Proc Natl Acad Sci USA (2013) 110(43):17253–8. doi: 10.1073/pnas.1308887110
27. Huang YY, Lin CW, Cheng NC, Cazzell SM, Chen HH, Huang KF, et al. Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients With Diabetic Foot Ulcers: A Randomized Clinical Trial. JAMA Netw Open (2021) 4(9):e2122607. doi: 10.1001/jamanetworkopen.2021.22607
28. Succar J, Douaiher J, Lancerotto L, Li Q, Yamaguchi R, Younan G, et al. The Role of Mouse Mast Cell Proteases in the Proliferative Phase of Wound Healing in Microdeformational Wound Therapy. Plast Reconstr Surg (2014) 134(3):459–67. doi: 10.1097/PRS.0000000000000432
29. Wulff BC, Wilgus TA. Mast Cell Activity in the Healing Wound: More Than Meets the Eye? Exp Dermatol (2013) 22(8):; 507–10. doi: 10.1111/exd.12169
30. Julier Z, Ark AJ, Briquez PS, Martino MML. Promoting Tissue Regeneration by Modulating the Immune System. Acta Biomater (2017) 15(53):13–28. doi: 10.1016/j.actbio.2017.01.056
31. Numata Y, Terui T, Okuyama R, Hirasawa N, Sugiura Y, Miyoshi I, et al. The Accelerating Effect of Histamine on the Cutaneous Wound-Healing Process Through the Action of Basic Fibroblast Growth Factor. J Invest Dermatol (2006) 126(6):1403–9. doi: 10.1038/sj.jid.5700253
32. Elieh Ali Komi D, Wöhrl S, Bielory L. Mast Cell Biology at Molecular Level: A Comprehensive Review. Clin Rev Allergy Immunoll (2020) 58(3):342–65. doi: 10.1007/s12016-019-08769-2
33. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast Cell Modulation of Neutrophil Influx and Bacterial Clearance at Sites of Infection Through TNF-Alpha. Nature (1996) 381:77–80. doi: 10.1038/381077a0
34. Liao B, Ouyang Q, Song H, Wang Z, Ou J, Huang J, et al. The Transcriptional Characteristics of Mast Cells Derived From Skin Tissue in Type 2 Diabetes Patients at the Single-Cell Level. Acta Histochem (2021) 123(7):151789. doi: 10.1016/j.acthis.2021.151789
35. Tellechea A, Bai S, Dangwal S, Theocharidis G, Nagai M, Koerner S, et al. Topical Application of a Mast Cell Stabilizer Improves Impaired Diabetic Wound Healing. J Invest Dermatol (2020) 140(4):901–911.e11. doi: 10.1016/j.jid.2019.08.449
36. Estevão LR, Medeiros JP, Simões RS, Arantes RM, Rachid MA, Silva RM, et al. Mast Cell Concentration and Skin Wound Contraction in Rats Treated With Brazilian Pepper Essential Oil (Schinus Terebinthifolius Raddi). Acta Cir Bras (2015) 30(4):289–95. doi: 10.1590/S0102-865020150040000008
37. Shiota N, Nishikori Y, Kakizoe E, Shimoura K, Niibayashi T, Shimbori C, et al. Pathophysiological Role of Skin Mast Cells in Wound Healing After Scald Injury: Study With Mast Cell-Deficient W/W(V) Mice. Int Arch Allergy Immunol (2010) 151(1):80–8. doi: 10.1159/000232573
38. Wulff BC, Parent AE, Meleski MA, DiPietro LA, Schrementi ME, Wilgus TA. Mast Cells Contribute to Scar Formation During Fetal Wound Healing. J Invest Dermatol (2012) 132(2):458–65. doi: 10.1038/jid.2011.324
39. Gri G, Frossi B, D’Inca F, Danelli L, Betto E, Mion F, et al. Mast Cell: An Emerging Partner in Immune Interaction. Front Immunol (2012) 3:120. doi: 10.3389/fimmu.2012.00120
40. Pierobon D, Raggi F, Cambieri I, Pelassa S, Occhipinti S, Cappello P, et al. Regulation of Langerhans Cell Functions in a Hypoxic Environment. J Mol Med (2016) 94(8):943–55. doi: 10.1007/s00109-016-1400-9
41. Kim TG, Kim SH, Lee MG. The Origin of Skin Dendritic Cell Network and its Role in Psoriasis. Int J Mol Sci (2017) 19(1):42. doi: 10.3390/ijms19010042
42. Segura E. Review of Mouse and Human Dendritic Cell Subsets. Methods Mol Biol (2016) 1423:3–15. doi: 10.1007/978-1-4939-3606-9_1
43. Su Q, Igyártó BZ. Keratinocytes Share Gene Expression Fingerprint With Epidermal Langerhans Cells via mRNA Transfer. J Invest Dermatol (2019) 139(11):2313–23. doi: 10.1016/j.jid.2019.05.006
44. Stojadinovic O, Yin N, Lehmann J, Pastar I, Kirsner RS, Tomic-Canic M. Increased Number of Langerhans Cells in the Epidermis of Diabetic Foot Ulcers Correlates With Healing Outcome. Immunol Res (2013) 57(1-3):222–8. doi: 10.1007/s12026-013-8474-z
45. Kohn S, Kohn D, Schiller D. Effect of Zinc Supplementation on Epidermal Langerhans’ Cells of Elderly Patients With Decubital Ulcers. J Dermatol (2000) 27(4):258–63. doi: 10.1111/j.1346-8138.2000.tb02161.x
46. Rajesh A, Stuart G, Real N, Tschirley A, Ahn J, Wise L, et al. Skin Antigen-Presenting Cells and Wound Healing: New Knowledge Gained and Challenges Encountered Using Mouse Depletion Models. Immunology (2021) 163(1):98–104. doi: 10.1111/imm.13311
47. Hasegawa H, Matsumoto T. Mechanisms of Tolerance Induction by Dendritic Cells In Vivo. Front Immunol (2018) 9:350. doi: 10.3389/fimmu.2018.00350
48. Waisman A, Lukas D, Clausen BE, Yogev N. Dendritic Cells as Gatekeepers of Tolerance. Semin Immunopathol (2017) 39(2):153–63. doi: 10.1007/s00281-016-0583-z
49. Gregorio J, Meller S, Conrad C, Di Nardo A, Homey B, Lauerma A, et al. Plasmacytoid Dendritic Cells Sense Skin Injury and Promote Wound Healing Through Type I Interferons. J Exp Med (2010) 207(13):2921–30. doi: 10.1084/jem.20101102
50. Sutoh Y, Mohamed RH, Kasahara M. Origin and Evolution of Dendritic Epidermal T Cells. Front Immunol (2018) 9:1059. doi: 10.3389/fimmu.2018.01059
51. Li Y, Wu J, Luo G, He W. Functions of Vgamma4 T Cells and Dendritic Epidermal T Cells on Skin Wound Healing. Front Immunol (2018) 9:1099. doi: 10.3389/fimmu.2018.01099
52. Chen C, Meng Z, Ren H, Zhao N, Shang R, He W, et al. The Molecular Mechanisms Supporting the Homeostasis and Activation of Dendritic Epidermal T Cell and its Role in Promoting Wound Healing. Burns Trauma (2021) 9:tkab009. doi: 10.1093/burnst/tkab009
53. Rani M, Zhang Q, Schwacha MG. Burn Wound γδ T-Cells Support a Th2 and Th17 Immune Response. J Burn Care Res (2014) 35(1):46–53. doi: 10.1097/01.bcr.0000440705.91099.cc
54. Zhu X, Zhu J. CD4 T Helper Cell Subsets and Related Human Immunological Disorders. Int J Mol Sci (2020) 21(21):8011. doi: 10.3390/ijms21218011
55. Nosbaum A, Prevel N, Truong HA, Mehta P, Ettinger M, Scharschmidt TC, et al. Cutting Edge: Eegulatory T Cells Facilitate Cutaneous Wound Healing. J Immunol (2016) 196(5):2010–4. doi: 10.4049/jimmunol.1502139
56. Zaiss DM, Minutti CM, Knipper JA. Immune- and non-Immune-Mediated Roles of Regulatory T-Cells During Wound Healing. Immunology (2019) 157(3):190–7. doi: 10.1111/imm.13057
57. Mezger M, Nording H, Sauter R, Graf T, Heim C, von Bubnoff N, et al. Platelets and Immune Responses During Thromboinflammation. Front Immunol (2019) 10:1731. doi: 10.3389/fimmu.2019.01731
58. Tokoro T, Makino I, Harada S, Okamoto K, Nakanuma S, Sakai S, et al. Interactions Between Neutrophils and Platelets in the Progression of Acute Pancreatitis. Pancreas (2020) 49(6):830–6. doi: 10.1097/MPA.0000000000001585
59. Opneja A, Kapoor S, Stavrou EX. Contribution of Platelets, the Coagulation and Fibrinolytic Systems to Cutaneous Wound Healing. Thromb Res (2019) 179:56–63. doi: 10.1016/j.thromres.2019.05.001
60. Etulain J. Platelets in Wound Healing and Regenerative Medicine. Platelets (2018) 29(6):556–68. doi: 10.1080/09537104.2018.1430357
61. Koenen RR. The Prowess of Platelets in Immunity and Inflammation. Thromb Haemost (2016) 116(4):605–12. doi: 10.1160/TH16-04-0300
62. López JA. Introduction to a Review Series on Platelets and Cancer. Blood (2021) 137(23):3151–2. doi: 10.1182/blood.2020010237
63. Sekhon UDS, Sen Gupta A. Platelets and Platelet-Onspired Biomaterials Technologies in Wound Healing Applications. ACS Biomater Sci Eng (2018) 4(4):1176–92. doi: 10.1021/acsbiomaterials.7b00013
64. Borovkova NV, Makarov MS, Ponomarev IN, Andreev YV, Storozheva MV, Budaev AA. Experimental Study of the Effect of Biological Matrixes With Stabilized and non-Stabilized Platelets on Reparative Process in the Wound Equivalent to Deep Burn. Bull Exp Biol Med (2020) 170(1):128–34. doi: 10.1007/s10517-020-05019-w
65. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of Platelet Concentrates: From Pure Platelet-Rich Plasma (P-PRP) to Leucocyte- and Platelet-Rich Fibrin (L-PRF). Trends Biotechnol (2009) 27(3):158–67. doi: 10.1016/j.tibtech.2008.11.009
66. Capion SC, Jørgensen HBL, Ågren MS, Daugaard H, Ribel-Madsen S, Marando D, et al. The Wound Healing Effect of Local Leukocyte Platelet-Rich Plasma After Total Hip Arthroplasty: A Randomized Controlled Trial. Wound Repair Regener (2021) 29(6):988–95. doi: 10.1111/wrr.12967
67. Huang CC, Thong HY. Rapid Wound Healing and Acne Scar Improvement After Ablative Fractional Carbon Dioxide Laser Treatment Combined With the Application of Platelet-Lyophilized Treatment (PLT). Clin Cosmet Investig Dermatol (2021) 14:715–21. doi: 10.2147/CCID.S316505
68. Abu-Humaidan AH, Ananthoju N, Mohanty T, Sonesson A, Alberius P, Schmidtchen A, et al. The Epidermal Growth Factor Receptor is a Regulator of Epidermal Complement Component Expression and Complement Activation. J Immunol (2014) 192(7):3355–64. doi: 10.4049/jimmunol
69. Markiewski MM, Daugherity E, Reese B, Karbowniczek M. The Role of Complement in Angiogenesis. Antibodies (Basel) (2020) 9(4):67. doi: 10.3390/antib9040067
70. Kolev M, Markiewski MM. Argeting Complement-Mediated Immunoregulation for Cancer Immunotherapy. Semin Immunol (2018) 37:85–97. doi: 10.1016/j.smim
71. Huber-Lang M, Kovtun A, Ignatius A. The Role of Complement in Trauma and Fracture Healing. Semin Immunol (2013) 25(1):73–8. doi: 10.1016/j.smim.2013.05.006
72. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: A Key System for Immune Surveillance and Homeostasis. Nat Immunol (2010) 11(9):785–97. doi: 10.1038/ni.1923
73. Sinno H, Prakash S. Complements and the Wound Healing Cascade: An Updated Review. Plast Surg Int (2013) 2013:146764. doi: 10.1155/2013/146764
74. Sinno H, Malhotra M, Lutfy J, Jardin B, Winocour S, Brimo F, et al. Accelerated Wound Healing With Topical Application of Complement C5. Plast Reconstr Surg (2012) 130(3):523–9. doi: 10.1097/PRS.0b013e31825dc02d
75. Sinno H, Malhotra M, Lutfy J, Jardin B, Winocour S, Brimo F, et al. Complements C3 and C5 Individually and in Combination Increase Early Wound Strength in a Rat Model of Experimental Wound Healing. Plast Surg Int (2013) 2013:243853. doi: 10.1155/2013/24385
76. Sinno H, Malholtra M, Lutfy J, Jardin B, Winocour S, Brimo F, et al. Topical Application of Complement C3 in Collagen Formulation Increases Early Wound Healing. J Dermatol Treat (2013) 24(2):141–7. doi: 10.3109/09546634.2011.631977
77. Cazander G, Jukema GN, Nibbering PH. Complement Activation and Inhibition in Wound Healing. Clin Dev Immunol (2012) 2012:534291. doi: 10.1155/2012/534291
78. Korkmaz HI, Ulrich MMW, van Wieringen WN, Vlig M, Emmens RW, Meyer KW, et al. The Local and Systemic Inflammatory Response in a Pig Burn Wound Model With a Pivotal Role for Complement. J Burn Care Res (2017) 38(5):e796–806. doi: 10.1097/BCR.0000000000000486
79. Rafail S, Kourtzelis I, Foukas PG, Markiewski MM, DeAngelis RA, Guariento M, et al. Complement Deficiency Promotes Cutaneous Wound Healing in Mice. J Immunol (2015) 194(3):1285–91. doi: 10.4049/jimmunol.1402354
80. Reis ES, Berger N, Wang X, Koutsogiannaki S, Doot RK, Gumas JT, et al. Safety Profile After Prolonged C3 Inhibition. Clin Immunol (2018) 197:96–106. doi: 10.1016/j.clim.2018.09.004
81. Cunnion KM, Krishna NK, Pallera HK, Pineros-Fernandez A, Rivera MG, Hair PS, et al. Complement Activation and STAT4 Expression Are Associated With Early Inflammation in Diabetic Wounds. PloS One (2017) 12(1):e0170500. doi: 10.1371/journal.pone.0170500
82. Gutjahr A, Heck F, Emtenani S, Hammers AK, Hundt JE, Muck P, et al. Bullous Pemphigoid Autoantibody-Mediated Complement Fixation Is Abolished by the Low-Molecular-Weight Heparin Tinzaparin Sodium. Br J Dermatol (2019) 181(3):593–4. doi: 10.1111/bjd.18156
83. Huebener P, Schwabe RF. Regulation of Wound Healing and Organ Fibrosis by Toll-Like Receptors. Biochim Biophys Acta (2013) 1832(7):1005–17. doi: 10.1016/j.bbadis.2012.11.017
84. Kumar V. Going, Toll-Like Receptors in Skin Inflammation and Inflammatory Diseases. EXCLI J (2021) 20:52–79. doi: 10.17179/excli2020-3114
85. Raja, Sivamani K, Garcia MS, Isseroff RR. Wound Re-Epithelialization: Modulating Keratinocyte Migration in Wound Healing. Front Biosci (2007) 12:2849–68. doi: 10.2741/2277
86. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Skin Immune Sentinels in Health and Disease. Nat Rev Immunol (2009) 9(10):679–91. doi: 10.1038/nri2622
87. Huang SM, Wu CS, Chiu MH, Wu CH, Chang YT, Chen GS. High Glucose Environment Induces M1 Macrophage Polarization That Impairs Keratinocyte Migration via TNF-α: An Important Mechanism to Delay the Diabetic Wound Healing. J Dermatol Sci (2019) 96(3):159–67. doi: 10.1016/j.jdermsci.2019.11.004
88. Klicznik MM, Szenes-Nagy AB, Campbell DJ, Gratz IK. Taking the Lead - How Keratinocytes Orchestrate Skin T Cell Immunity. Immunol Lett (2018) 200:43–51. doi: 10.1016/j.imlet.2018.06.009
89. Krausgruber T, Fortelny N, Fife-Gernedl V, Senekowitsch M, Schuster LC, Lercher A. Structural Cells are Key Regulators of Organ-Specific Immune Responses. Nature (2020) 583(7815):296–302. doi: 10.1038/s41586-020-2424-4
90. Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M. Fibroblasts Regulate the Switch From Acute Resolving to Chronic Persistent Inflammation. Trends Immunol (2001) 22(4):199–204. doi: 10.1016/s1471-4906(01)01863-4
91. Paish HL, Kalson NS, Smith GR, Del Carpio Pons A, Baldock TE, Smith N, et al. Fibroblasts Promote Iinflammation and Pain via IL-1αiinduction of the Monocyte Chemoattractant Chemokine (C-C Motif) Ligand 2. Am J Pathol (2018) 188(3):696–714. doi: 10.1016/j.ajpath.2017.11.007
92. Cooper PO, Haas MR, Noonepalle SKR, Shook BA. Dermal Drivers of Injury-Induced Inflammation: Contribution of Adipocytes and Fibroblasts. Int J Mol Sci (2021) 22(4):1933. doi: 10.3390/ijms22041933
93. Bautista-Hernández LA, Gómez-Olivares JL, Buentello-Volante B, Bautista-de Lucio VM. Fibroblasts: The Unknown Sentinels Elicitingimmune Responses Against Microorganisms. Eur J Microbiol Immunol (Bp) (2017) 7(3):151–7. doi: 10.1556/1886.2017.00009
94. Buckley CD, Halder S, Hardie D, Reynolds G, Torensma R, De Villeroche VJ. A Stromal Address Code Defined by Fibroblasts. Cell Immunol (2005) 26(3):150–6. doi: 10.1016/j.it.2004.11.014
96. Poinas A, Perrot P, Lorant J, Nerrière O, Nguyen JM, Saiagh S, et al. CICAFAST: Comparison of a Biological Dressing Composed of Fetal Fibroblasts and Keratinocytes on a Split-Thickness Skin Graft Donor Site Versus a Traditional Dressing: A Randomized Controlled Trial. Trials (2019) 20(1):612. doi: 10.1186/s13063-019-3718-4
97. Muller WA. Transendothelial Migration: Unifying Principles From the Endothelial Perspective. Immunol Rev (2016) 273(1):61–75. doi: 10.1111/imr.12443
98. Lyck R, Enzmann G. The Physiological Roles of ICAM-1 and ICAM-2 in Neutrophil Migration Into Tissues. Curr Opin Hematol (2015) 22(1):53–9. doi: 10.1097/MOH.0000000000000103
99. Mitroulis I, Alexaki VI, Kourtzelis I, Ziogas A, Hajishengallis G, Chavakis T. Leukocyte Integrins: Role in Leukocyte Recruitment and as Therapeutic Targets in Inflammatory Disease. Pharmacol Ther (2015) 147:123–35. doi: 10.1016/j.pharmthera.2014.11.008
100. Schmidt EP, Lee WL, Zemans RL, Yamashita C, Downey GP. On, Around, and Through: Neutrophil-Endothelial Interactions in Innate Immunity. Physiology (2011) 26(5):334–47. doi: 10.1152/physiol.00011.2011
101. Santiago-Delpin EA. The Endothelium and Early Immune Activation: New Perspective and Interactions. Transplant Proc (2004) 36(6):1709–13. doi: 10.1016/j.transproceed.2004.06.068
102. Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ, et al. Bacterial Lipopolysaccharide Activates NF-kB Through Toll-Like Receptor 4 (TLR-4) in Cultured Human Dermal Endothelial Cells. J Biol Chem (2000) 275(15):11058–63. doi: 10.1074/jbc.275.15.11058
103. Nilforoushzadeh MA, Sisakht MM, Amirkhani MA, Seifalian AM, Banafshe HR, Verdi J, et al. Engineered Skin Graft With Stromal Vascular Fraction Cells Encapsulated in Fibrin-Collagen Hydrogel: A Clinical Study for Diabetic Wound Healing. J Tissue Eng Regener Med (2020) 14(3):424–40. doi: 10.1002/term.3003
104. Boyd DF, Thomas PG. Towards Integrating Extracellular Matrix and Immunological Pathways. Cytokine (2017) 98:79–86. doi: 10.1016/j.cyto.2017.03.004
105. Chester D, Brown AC. The Role of Biophysical Properties of Provisional Matrix Proteins in Wound Repair. Matrix Biol (2017) 60-61:124–40. doi: 10.1016/j.matbio.2016.08.004
106. Magnusson MK, Mosher DF. Fibronectin Structure, Assembly, and Cardiovascular Implications. Arterioscler Thromb Vasc Biol (1998) 18(9):1363–70. doi: 10.1161/01.atv.18.9.1363
107. Barker TH, Engler AJ. The Provisional Matrix: Setting the Stage for Tissue Repair Outcomes. Matrix Biol (2017) 60-61:1–4. doi: 10.1016/j.matbio.2017.04.003
108. Rousselle P, Montmasson M, Garnier C. Extracellular Matrix Contribution to Skin Wound Re-Epithelialization. Matrix Biol (2019) 75-76:12–26. doi: 10.1016/j.matbio.2018.01.002
109. Wight TN. Provisional Matrix: A Role for Versican and Hyaluronan. Matrix Biol (2017) 60-61:38–56. doi: 10.1016/j.matbio.2016.12.001
110. Weisel JW, Litvinov RI. Fibrin Formation, Structure and Properties. Subcell Biochem (2017) 82:405–56. doi: 10.1007/978-3-319-49674-0_13
111. Clark RA. Fibrin and Wound Healing. Ann N Y Acad Sci (2001) 936:355–67. doi: 10.1111/j.1749-6632.2001.tb03522.x
112. Lenselink EA. Role of Fibronectin in Normal Wound Healing. Int Wound J (2015) 12(3):313–6. doi: 10.1111/iwj.12109
113. Chen WY, Abatangelo G. Functions of Hyaluronan in Wound Repair. Wound Repair Regener (1999) 7(2):79–89. doi: 10.1046/j.1524-475x.1999.00079.x
114. Nyman E, Huss F, Nyman T, Junker J, Kratz G. Hyaluronic Acid, an Important Factor in the Wound Healing Properties of Amniotic Fluid: In Vitro Studies of Re-Epithelialisation in Human Skin Wounds. J Plast Surg Handb Surg (2013) 47(2):89–92. doi: 10.3109/2000656X.2012.733169
115. Neuman MG, Nanau RM, Oruña-Sanchez L, Coto G. Hyaluronic Acid and Wound Healing. Wounds (2016) 28(3):78–88. doi: 10.18433/j3k89d
116. Vaday GG, Lider O. Extracellular Matrix Moieties, Cytokines, and Enzymes_ Dynamic Effects on Immune Cell Behavior and Inflammation. J Leukoc Biol (2000) 67(2):149–59. doi: 10.1002/jlb.67.2.149
117. Morwood SR, Nicholson LB. Modulation of the Immune Response by Extracellular Matrix Proteins. Arch Immunol Ther Exp (2006) 54(6):367–74. doi: 10.1007/s00005-006-0043-x
118. Levi N, Papismadov N, Solomonov I, Sagi I, Krizhanovsky V. The ECM Path of Senescence in Aging: Components and Modifiers. FEBS J (2020) 287(13):2636–46. doi: 10.1111/febs.15282
119. Harding K, Aldons P, Edwards H, Stacey M, Finlayson K, Gibb M, et al. Effectiveness of an Acellular Synthetic Matrix in the Treatment of Hard-to-Heal Leg Ulcers. Int Wound J (2014) 11(2):129–37. doi: 10.1111/iwj.12115
120. Gilligan AM, Waycaster CR, Landsman AL. Wound Closure in Patients With DFU: A Cost-Effectiveness Analysis of Two Cellular/Tissue-Derived Products. J Wound Care (2015) 24(3):149–56. doi: 10.12968/jowc.2015.24.3.149
121. Lietha D, Izard T. Roles of Membrane Domains in Integrin-Mediated Cell Adhesion. Int J Mol Sci (2020) 21(15):5531. doi: 10.3390/ijms21155531
122. Zulueta-Coarasa T, Fernandez-Gonzalez R. Tension (Re)Builds: Bbiophysical Mechanisms of Embryonic Wound Repair. Mech Dev (2017) 144(Pt A):43–52. doi: 10.1016/j.mod.2016.11.004
123. Orsini EM, Perelas A, Southern BD, Grove LM, Olman MA, Scheraga RG. Stretching the Function of Innate Immune Cells. Front Immunol (2021) 12:767319. doi: 10.3389/fimmu.2021.767319
124. Sun Z, Guo SS, Fässler R. Integrin-Mediated Mechanotransduction. J Cell Biol (2016) 215(4):445–56. doi: 10.1083/jcb.201609037
125. Cui K, Ardell CL, Podolnikova NP, Yakubenko VP. Distinct Migratory Properties of M1, M2, and Resident Macrophages Are Regulated by αβ and αβ Integrin-Mediated Adhesion. Front Immunol (2018) 9:2650. doi: 10.3389/fimmu.2018.02650
126. Cui K, Podolnikova NP, Bailey W, Szmuc E, Podrez EA, Byzova TV, et al. Inhibition of Integrin αβ-Mediated Macrophage Adhesion to End Product of Docosahexaenoic Acid (DHA) Oxidation Prevents Macrophage Accumulation During Inflammation. J Biol Chem (2019) 294(39):14370–82. doi: 10.1074/jbc.RA119.009590
127. Atcha H, Jairaman A, Holt JR, Meli VS, Nagalla RR, Veerasubramanian PK, et al. Mechanically Activated Ion Channel Piezo1 Modulates Macrophage Polarization and Stiffness Sensing. Nat Commun (2021) 12(1):3256. doi: 10.1038/s41467-021-23482-5
128. Michalick L, Kuebler WM. TRPV4-A Missing Link Between Mechanosensation and Immunity. Front Immunol (2020) 11:413. doi: 10.3389/fimmu.2020.00413
129. Tang KM, Chen W, Tang ZH, Yu XY, Zhu WQ, Zhang SM, et al. Role of the Hippo-YAP/NF-κb Signaling Pathway Crosstalk in Regulating Biological Behaviors of Macrophages Under Titanium Ion Exposure. J Appl Toxicol (2021) 41(4):561–71. doi: 10.1002/jat.4065
130. Harn HI, Ogawa R, Hsu CK, Hughes MW, Tang MJ, Chuong CM. The Tension Biology of Wound Healing. Exp Dermatol (2019) 28(4):464–71. doi: 10.1111/exd.13460
131. Slater B, Li J, Indana D, Xie Y, Chaudhuri O, Kim T. Transient Mechanical Interactions Between Cells and Viscoelastic Extracellular Matrix. Soft Matter (2021) 17(45):10274–85. doi: 10.1039/d0sm01911a
132. Winter GD. Formation of the Scab and the Rate of Epithelization of Superficial Wounds in the Skin of the Young Domestic Pig. Nature (1962) 193:293–4. doi: 10.1038/193293a0
133. Jones J. Winter’s Concept of Moist Wound Healing: A Review of the Evidence and Impact on Clinical Practice. J Wound Care (2005) 14(6):273–6. doi: 10.12968/jowc.2005.14.6.26794
134. Pollack SV. Wound Healing: A Review. II. Environmental Factors Affecting Wound Healing. J Dermatol Surg Oncol (1979) 5(6):477–81. doi: 10.1111/j.1524-4725.1979.tb00699.x
135. Brand HS, Ligtenberg AJ, Veerman EC. Saliva and Wound Healing. Monogr Oral Sci (2014) 24:52–60. doi: 10.1159/000358784
136. Andriessen A, Polignano R, Abel M. Monitoring the Microcirculation to Evaluate Dressing Performance in Patients With Venous Leg Ulcers. J Wound Care (2009) 18(4):145–50. doi: 10.12968/jowc.2009.18.4.41606
137. Fierheller M, Sibbald RG. A Clinical Investigation Into the Relationship Between Increased Periwound Skin Temperature and Local Wound Infection in Patients With Chronic Leg Ulcers. Adv Skin Wound Care (2010) 23(8):369–79. doi: 10.1097/01.ASW.0000383197.28192.98. quiz 380-1.
138. Power G, Moore Z, O'Connor T.Measurement of Ph, Exudate Composition and Temperature in Wound Healing: A Systematic Review. J Wound Care (2017) 26(7):381–97. doi: 10.12968/jowc.2017.26.7.381
139. Kruse CR, Nuutila K, Lee CC, Kiwanuka E, Singh M, Caterson EJ, et al. The External Microenvironment of Healing Skin Wounds. Wound Repair Regener (2015) 23(4):456–64. doi: 10.1111/wrr.12303
140. Sessler DI. Perioperative Thermoregulation and Heat Balance. Lancet (2016) 387(10038):2655–64. doi: 10.1016/S0140-6736(15)00981-2
141. Bu N, Zhao E, Gao Y, Zhao S, Bo W, Kong Z, et al. Association Between Perioperative Hypothermia and Surgical Site Infection: A Meta-Analysis. Med (Baltimore) (2019) 98(6):e14392. doi: 10.1097/MD.0000000000014392
142. Petrofsky JS, Lawson D, Suh HJ, Rossi C, Zapata K, Broadwell E, et al. The Influence of Local Versus Global Heat on the Healing of Chronic Wounds in Patients With Diabetes. Diabetes Technol Ther (2007) 9(6):535–44. doi: 10.1089/dia.2007.0231
143. Gottrup F, Dissemond J, Baines C, Frykberg R, Jensen PØ, Kot J, et al. Use of Oxygen Therapies in Wound Healing. J Wound Care (2017) 26(Sup5):S1–S43. doi: 10.12968/jowc.2017.26.Sup5.S1
144. Dadkhah Tehrani F, Shabani I, Shabani A. A Hybrid Oxygen-Generating Wound Dressing Based on Chitosan Thermosensitive Hydrogel and Decellularized Amniotic Membrane. Carbohydr Polym (2022) 281:119020. doi: 10.1016/j.carbpol.2021.119020
145. Percival SL, McCarty S, Hunt JA, Woods EJ. The Effects of pH on Wound Healing, Biofilms, and Antimicrobial Efficacy. Wound Repair Regener (2014) 22(2):174–86. doi: 10.1111/wrr.12125
146. Trevani AS, Andonegui G, Giordano M, López DH, Gamberale R, Minucci F, et al. Extracellular Acidification Induces Human Neutrophil Activation. J Immunol (1999) 162(8):4849–57.
147. Nahas GG, Tannieres ML, Lennon JF. Direct Measurement of Leukocyte Motility: Effects of pH and Temperature. Proc Soc Exp Biol Med (1971) 138(1):350–2. doi: 10.3181/00379727-138-35894
148. Tashkandi H. Honey in Wound Healing: An Updated Review. Open Life Sci (2021) 16(1):1091–100. doi: 10.1515/biol-2021-0084
149. Kosten IJ, van de Ven R, Thon M, Gibbs S, de Gruijl TD. Comparative Phenotypic and Functional Analysis of Migratory Dendritic Cell Subsets From Human Oral Mucosa and Skin. PloS One (2017) 12(7):e0180333. doi: 10.1371/journal.pone.0180333
150. Deckers J, Hammad H, Hoste E. Langerhans Cells: Sensing the Environment in Health and Disease. Front Immunol (2018) 9:93. doi: 10.3389/fimmu.2018.00093
151. Miller LS, Modlin RL. Toll-Like Receptors in the Skin. Semin Immunopathol (2007) 29(1):15–26. doi: 10.1007/s00281-007-0061-8
152. R Arenas Gómez CM, Sabin KZ, Echeverri K. Wound Healing Across the Animal Kingdom: Crosstalk Between the Immune System and the Extracellular Matrix. Dev Dyn (2020) 249(7):834–46. doi: 10.1002/dvdy.178
153. Rayahin JE, Buhrman JS, Zhang Y, Koh TJ, Gemeinhart RA. High and Low Molecular Weight Hyaluronic Acid Differentially Influence Macrophage Activation. ACS Biomater Sci Eng (2015) 1(7):481–93. doi: 10.1021/acsbiomaterials.5b00181
154. Maquart FX, Monboisse JC. Monboisse, Extracellular Matrix and Wound Healing. Pathol Biol (2014) 62(2):91–5. doi: 10.1016/j.patbio.2014.02.007
155. Sun L, Li J, Gao W, Shi M, Tang F, Fu X, et al. Coaxial Nanofibrous Scaffolds Mimicking the Extracellular Matrix Transition in the Wound Healing Process Promoting Skin Regeneration Through Enhancing Immunomodulation. J Mater Chem B (2021) 9(5):1395–405. doi: 10.1039/d0tb01933j
156. Stefan LM, Iosageanu A, Ilie D, Stanciuc AM, Matei C, Berger D, et al. Extracellular Matrix Biomimetic Polymeric Membranes Enriched With Silver Nanoparticles for Wound Healing. BioMed Mater (2021) 16(3). doi: 10.1088/1748-605X/abe55d. Online ahead of print.
157. Burgess JL, Wyant WA, Abdo Abujamra B, Kirsner RS, Jozic I. Diabetic Wound-Healing Science. Med (Kaunas) (2021) 57(10):1072. doi: 10.3390/medicina57101072
158. Zhao R, Liang H, Clarke E, Jackson C, Xue M. Inflammation in Chronic Wounds. Int J Mol Sci (2016) 17(12):2085. doi: 10.3390/ijms17122085
159. Wang GH, Ma KL, Zhang Y, Hu ZB, Liu L, Lu J, et al. Platelet Microparticles Contribute to Aortic Vascular Endothelial Injury in Diabetes via the Mtorc1 Pathway. Acta Pharmacol Sin (2019) 40(4):468–76. doi: 10.1038/s41401-018-0186-4
160. Liu D, Yang P, Gao M, Yu T, Shi Y, Zhang M, et al. NLRP3 Activation Induced by Neutrophil Extracellular Traps Sustains Inflammatory Response in the Diabetic Wound. Clin Sci (Lond) (2019) 133(4):565–82. doi: 10.1042/CS20180600
161. Torregrossa M, Kakpenova A, Simon JC, Franz S. Modulation of Macrophage Functions by ECM-Inspired Wound Dressings - a Promising Therapeutic Approach for Chronic Wounds. Biol Chem (2021) 402(11):1289–307. doi: 10.1515/hsz-2021-0145
162. Wolf SJ, Melvin WJ, Gallagher K. Macrophage-Mediated Inflammation in Diabetic Wound Repair. Semin Cell Dev Biol (2021) 119:111–8. doi: 10.1016/j.semcdb.2021.06.013
163. Louiselle AE, Niemiec SM, Zgheib C, Liechty KW. Macrophage Polarization and Diabetic Wound Healing. Transl Res (2021) 236:109–16. doi: 10.1016/j.trsl.2021.05.006
164. Tellechea A, Leal EC, Kafanas A, Auster ME, Kuchibhotla S, Ostrovsky Y, et al. Mast Cells Regulate Wound Healing in Diabetes. Diabetes (2016) 65(7):2006–19. doi: 10.2337/db15-0340
165. Joshi N, Pohlmeier L, Ben-Yehuda Greenwald M, Haertel E, Hiebert P, Kopf M, et al. Comprehensive Characterization of Myeloid Cells During Wound Healing in Healthy and Healing-Impaired Diabetic Mice. Eur J Immunol (2020) 50(9):1335–49. doi: 10.1002/eji.201948438
166. Huang Y, Kyriakides TR. The Role of Extracellular Matrix in the Pathophysiology of Diabetic Wounds. Matrix Biol Plus (2020) 6-7:100037. doi: 10.1016/j.mbplus.2020.100037
167. Pradhan RN, Krishnamurty AT, Fletcher AL, Turley SJ, Müller S. A Bird’s Eye View of Fibroblast Heterogeneity: A Pan-Disease, Pan-Cancer Perspective. Immunol Rev (2021) 302(1):299–320. doi: 10.1111/imr.12990
168. Andrews N, Serviss JT, Geyer N, Andersson AB, Dzwonkowska E, Šutevski I, et al. An Unsupervised Method for Physical Cell Interaction Profiling of Complex Tissues. Nat Methods (2021) 18(8):912–20. doi: 10.1038/s41592-021-01196-2
169. Raziyeva K, Kim Y, Zharkinbekov Z, Kassymbek K, Jimi S, Saparov A. Immunology of Acute and Chronic Wound Healing. Biomolecules (2021) 11(5):700. doi: 10.3390/biom11050700
Keywords: wound healing, inflammatory microenvironment, inflammatory cells, non-inflammatory cells, extracellular matrix
Citation: Wang Z, Qi F, Luo H, Xu G and Wang D (2022) Inflammatory Microenvironment of Skin Wounds. Front. Immunol. 13:789274. doi: 10.3389/fimmu.2022.789274
Received: 04 October 2021; Accepted: 09 February 2022;
Published: 01 March 2022.
Edited by:
Markus H. Hoffmann, University of Lübeck, GermanyReviewed by:
Wendong Gao, Queensland University of Technology, AustraliaChristoph M. Hammers, University of Lübeck, Germany
Copyright © 2022 Wang, Qi, Luo, Xu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Guangchao Xu, R3VhbmdjaGFvX1h1QHptdS5lZHUuY24=; Dali Wang, ZGFsaXdhbmd6eUBzaW5hLmNvbQ==
†These authors have contributed equally to this work